These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8587080)

  • 21. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
    Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA
    Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine: an activity marker in Behçet's disease?
    Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction.
    Kawakami T; Ohashi S; Kawa Y; Takahama H; Ito M; Soma Y; Mizoguchi M
    Arch Dermatol; 2004 May; 140(5):570-4. PubMed ID: 15148101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK.
    Duan R; Remeijer L; van Dun JM; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):277-84. PubMed ID: 17197544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
    Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
    Losa García JE; Rodríguez FM; Martín de Cabo MR; García Salgado MJ; Losada JP; Villarón LG; López AJ; Arellano JL
    Mediators Inflamm; 1999; 8(1):43-51. PubMed ID: 10704089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
    Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
    J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease.
    Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M
    Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behçet's disease.
    Wang LM; Kitteringham N; Mineshita S; Wang JZ; Nomura Y; Koike Y; Miyashita E
    Arch Dermatol Res; 1997 Jul; 289(8):444-7. PubMed ID: 9266021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestations.
    Talaat RM; Sibaii H; Bassyouni IH; El-Wakkad A
    Eur Cytokine Netw; 2019 Mar; 30(1):15-22. PubMed ID: 31122907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of interferon-alpha treatment on serum IL-6, IL-8, TNF-alpha and soluble TNF-alpha receptors in Behçet's disease.
    Direskeneli H; Fresko I; Hamuryudan V
    Scand J Rheumatol; 2005; 34(1):75-6. PubMed ID: 15903033
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease.
    Freire Ade L; Bertolo MB; de Pinho AJ; Samara AM; Fernandes SR
    Clin Rheumatol; 2004 Jun; 23(3):203-5. PubMed ID: 15168145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease.
    Kosar A; Haznedaroglu S; Karaaslan Y; Büyükasik Y; Haznedaroglu IC; Ozath D; Sayinalp N; Ozcebe O; Kirazli S; Dündar S
    Rheumatol Int; 1999; 19(1-2):11-4. PubMed ID: 10651074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma and whole-blood chemokine levels in patients with Behcet's disease.
    Kaburaki T; Fujino Y; Kawashima H; Merino G; Numaga J; Chen J; Matsushima K
    Graefes Arch Clin Exp Ophthalmol; 2003 May; 241(5):353-8. PubMed ID: 12712358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of serum resistin levels in patients with ocular and non-ocular Behçet's disease.
    Yalçindag FN; Yalçindag A; Batioglu F; Caglayan O; Kisa U; Ozdemir O
    Can J Ophthalmol; 2008 Aug; 43(4):473-5. PubMed ID: 18711464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet's disease with ocular involvement.
    Bardak Y; Aridoğan BC
    Ocul Immunol Inflamm; 2004 Mar; 12(1):53-8. PubMed ID: 15209464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-8 producing cells in patients with Behçet's disease.
    Mantas C; Direskeneli H; Oz D; Yavuz S; Akoglu T
    Clin Exp Rheumatol; 2000; 18(2):249-51. PubMed ID: 10812500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.